Indicator summary: Leaning bullish (3 bullish, 2 bearish, 0 neutral). As of 2026-11-05, the close was $218.11: 13.2% above the 50-day average and 10.0% above the 200-day average, which is falling. RSI (14) is 77, overbought. MACD is bullish. The stock sits 63% of the way up its 52-week range of $166.10 to $248.90, on 3.5x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $192.72 | Price 13.2% above |
| 200-day average | $198.22 | Price 10.0% above, average falling |
| 50 vs 200-day | 50 below 200 | Death-cross alignment |
| RSI (14) | 77 | Overbought |
| MACD (12, 26, 9) | +3.60 vs +2.08 | Line above signal |
| 52-week range | $166.10 to $248.90 | 63% of the way up the range |
| Volume vs 20-day average | 3.5x | Heavy |
Base rates use TM's own daily history since 1999; they describe the past, not a forecast.
As of 2026-11-05, TM's 14-day RSI is 77, which is overbought (above 70). When it had RSI above 70 (413 days), it was higher 63 trading days later 55% of the time, median +1.9%.
Yes. TM closed at $218.11 on 2026-11-05, 10.0% above its 200-day average of $198.22, which is falling. When it closed above its 200-day average (3,660 days), it was higher 63 trading days later 59% of the time, median +2.9%.
Yes. TM closed at $218.11 on 2026-11-05, 13.2% above its 50-day average of $192.72. When it closed above its 50-day average (3,619 days), it was higher 63 trading days later 59% of the time, median +3.0%.
No cross in the last 10 trading days. As of 2026-11-05 the MACD line is +3.60 against a signal line of +2.08, so MACD is bullish.
No. At $218.11 it sits 63% of the way up its 52-week range of $166.10 to $248.90, 12.4% below the high.
Leaning bullish: 3 of 5 indicators are bullish and 2 bearish as of 2026-11-05 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Bearish, from the chart signal model.
TM analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.